Roy Krumbholz

SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids

Paul Mason, Beirong Liang, Lingyun Li et al. · PLoS ONE · 2012 · 166 citations · Full text

Pathology, Cell Death, Reference Scd1 Inhibitors +16

Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment

Leslie Kurtzberg, Stephanie Roth, Roy Krumbholz et al. · Clinical Cancer Research · 2011 · 49 citations

Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors

Leslie Kurtzberg, Traci E. Battle, Cécile Rouleau et al. · Molecular Cancer Therapeutics · 2008 · 37 citations

Tumor Biology, Oncology, Human Tumor Xenografts +14

Anti-Endosialin Antibody–Drug Conjugate: Potential in Sarcoma and Other Malignancies

Cécile Rouleau, Diego A. Gianolio, Robert Smale et al. · Molecular Cancer Therapeutics · 2015 · 36 citations

Tumor Biology, Malignant Disease, Medicine +12

Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates

Diego A. Gianolio, Cécile Rouleau, William E. Bauta et al. · Cancer Chemotherapy and Pharmacology · 2012 · 33 citations

Tumor Biology, Novel Antibody–drug Conjugates, Drug Targeting +12